Short Reads | GenomeWeb

Short Reads

Premium

Sequenom faces class action lawsuits on behalf of shareholders after the firm announced that it will delay the launch of a test for Down syndrome on discovering that employees had mishandled R&D test data and results. Sequenom CEO Harry Stylli said four employees had been suspended and that the company put a new team in place to oversee studies of its prenatal diagnostics.

John Rossi, co-founder of Dicerna Pharmaceuticals, won the 2008 Cozzarelli Prize from the Proceedings of the National Academy of Sciences' Editorial Board for work using microRNAs for gene silencing.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Biomedical research projects are generating a ton of data that still needs to be analyzed, NPR reports.

Theranos is retiring some of its board members, including Henry Kissinger and George Shultz, Business Insider reports.

The heads of 29 scientific societies and some 2,300 researchers call on President-elect Donald Trump to rely on and support science in two separate letters.

In Science this week: genetically modified flu virus could be key to new live vaccines, and more.